- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Epithelial Cancer in United States
Total 30062 results
-
University of IowaTerminatedOvarian CancerUnited States
-
Loyola UniversityCelgene CorporationWithdrawnOvarian CancerUnited States
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity Cancer | Fallopian Tube AdenocarcinomaUnited States
-
AA SecordMerck Sharp & Dohme LLCCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Gynecologic Neoplasms | Uterine Endometrial CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; AIM ImmunoTech Inc.SuspendedOvarian Cancer | Cancer of the Ovary | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Cancer of OvaryUnited States
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
University of WashingtonCompletedOvarian CancerUnited States
-
NYU Langone HealthCompletedOvarian CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Dana-Farber Cancer InstitutePatty Brisben Foundation For Women's Sexual HealthCompletedOvarian CancerUnited States
-
University of WashingtonCompletedOvarian CancerUnited States
-
University of ArizonaCephalonCompletedOvarian CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
University of ChicagoCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)UnknownOvarian CancerUnited States
-
Weill Medical College of Cornell UniversityTerminated
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Recurrent Ovarian Epithelial Cancer | Malignant Tumor of PeritoneumUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer | Hereditary Breast/Ovarian Cancer - BRCA1 | Hereditary Breast/Ovarian Cancer...United States
-
University of GlasgowCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian Cancer | Malignant Tumor of PeritoneumUnited States
-
William CarsonCompletedHepatocellular Carcinoma | Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell TumorUnited States
-
Memorial Sloan Kettering Cancer CenterTerminatedOvarian Cancer | Sexual DysfunctionUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedSolid TumorsUnited States
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Regeneron PharmaceuticalsNot yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States
-
Oncolix, Inc.UnknownOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, United States
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
Astellas Pharma IncAgensys, Inc.CompletedCarcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian CancerUnited States
-
amy tierstenAstraZeneca; Eisai Inc.CompletedRecurrent Ovarian Cancer | HER2-Negative Metastatic Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
Duke UniversityCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnOvarian CancerUnited States
-
University of South AlabamaMayo Clinic; Washington University School of Medicine; Tulane University Health... and other collaboratorsCompletedOvarian CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of PennsylvaniaCompleted
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterKeryx BiopharmaceuticalsCompletedOvarian CancerUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Withdrawn
-
M.D. Anderson Cancer CenterTerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
University of Maryland, College ParkCompleted